Search

everythinglearnresearchcommunity

for

Search:↓

Combining triamcinolone microinjections with minoxidil improves hair growth in women more than minoxidil alone.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Platelet-rich plasma is more effective and satisfactory than hyaluronic acid for knee osteoarthritis.

Kerion cases had longer disease duration but responded well to antifungal treatments.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Ruxolitinib cream may help treat severe hair loss in children.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

Topical imiquimod is as effective as 5-fluorouracil for treating actinic keratosis, with about a 5% risk of it turning into squamous cell carcinoma.

A 940nm laser effectively reduces inflammation in rat joints.

Excision with primary closure is an excellent treatment for extensive acne keloidalis nuchae.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Keratoacanthoma changes as it grows, showing different hair follicle characteristics at each stage.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

SIG-1451 could be a promising new treatment for atopic dermatitis.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Low level laser or LED therapy combined with infiltrations may help hair growth.

Dexmedetomidine-loaded microneedles effectively reduce pain without sedation.

PRP is a promising and safe treatment for early to moderate knee osteoarthritis but needs standardized protocols.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Access to JAK inhibitor therapy for alopecia areata patients is difficult, especially for racial minorities.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.